FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to pharmaceutical industry and concerns a preparation of nalbuphine hydrochloride for injections. The preparation contains (wt %): nalbuphine hydrochloride 1.0-2.0; citric acid: 1.26; sodium citrate: 0.94; sodium chloride: 0,1; sodium metabisulfite: 0.1; sodium metabisulfites: the rest.
EFFECT: invention may be used to relief pain syndromes of moderate and intense severity in myocardial infarction, in preparation for surgery, during the postoperative period, and also as an analgesic co-preparation for general anaesthesia.
2 cl, 4 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTION SOLUTION WITH EXPRESSED ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2004 |
|
RU2254852C1 |
| PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
| HIGH-STABLE PHARMACEUTICAL FORMULATION OF LYOPHILISATE OF 3-OXYPYRIDINE AND METHYLPYRIDINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 2012 |
|
RU2504376C1 |
| BUTORPHANOL-BASE INJECTION SOLUTION POSSESSING ANALGESIC EFFECT | 2006 |
|
RU2312662C1 |
| ANALGETIC AGENT AND A METHOD OF ITS PREPARING | 1997 |
|
RU2117481C1 |
| MEANS FOR EFFECTIVE CUPPING OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION | 2016 |
|
RU2622980C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING NALBUPHINE HYDROCHLORIDE, USING IT FOR TREATING MODERATE TO SEVERE PAIN SYNDROME | 2012 |
|
RU2513514C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTE FOR INTRAVENOUS AND INTRAMUSCULAR INJECTION AND ITS PRODUCTION PROCESS | 2015 |
|
RU2637168C2 |
| PREPARATION FOR SYMPTOMATIC TREATMENT OF LOCOMOTOR APPARATUS DISEASES AND PREPARATION METHOD THEREOF | 2016 |
|
RU2614958C1 |
| PHARMACEUTICAL COMPOSITION FOR INJECTIONS | 2008 |
|
RU2380089C2 |
